Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects

NCT00854009 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BLI-489
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer